
AdaptHealth Corp (AHCO) Stock Forecast & Price Target
AdaptHealth Corp (AHCO) Analyst Ratings
Bulls say
AdaptHealth Corp is poised for significant growth, with expectations of a 12–15% annual topline increase driven by sustained investments in technology and strategic mergers and acquisitions in a fragmented market. The recent acquisition of AeroCare is anticipated to strengthen the company's national footprint and value proposition with payors, facilitating advancements in its connected health strategy. Furthermore, the company's scalable platform and low-cost infrastructure are expected to enhance operational efficiency, leading to strong organic growth and improved margin expansion through effective cross-selling opportunities.
Bears say
AdaptHealth Corp has experienced a decline in both diabetes and sleep revenues, with diabetes revenue dropping 8.0% year-over-year and sleep revenue falling 3.0% year-over-year, indicating challenges in maintaining market share in competitive segments. Additionally, the company has revised its 2025 revenue and adjusted EBITDA guidance downward by $40 million and $5 million, respectively, primarily due to the sale of certain incontinence assets. The overall outlook is further compounded by concerns about acquisition integration challenges and the inability to achieve operating leverage on organic growth, suggesting potential weaknesses in its business model moving forward.
This aggregate rating is based on analysts' research of AdaptHealth Corp and is not a guaranteed prediction by Public.com or investment advice.
AdaptHealth Corp (AHCO) Analyst Forecast & Price Prediction
Start investing in AdaptHealth Corp (AHCO)
Order type
Buy in
Order amount
Est. shares
0 shares